Jason M. NotoSenior Vice President, US Market Access & Alliance Management at AVEO Oncology, An LG Chem CompanySpeaker
Profile
Jason Noto is a senior biopharmaceutical commercial executive with more than 25 years of leadership experience building and leading high-performing commercial organizations across oncology and specialty therapeutics. His expertise spans market access, sales, marketing, patient services, alliance management, trade and distribution, and commercialization strategy, with a strong track record of leading organizations through launch readiness, growth, and operational scale.
Jason currently serves as Senior Vice President, Market Access & Alliance Management at AVEO Oncology, an LG Chem company, where he leads enterprise market access and commercialization functions, including pricing and contracting strategy, patient services, national and federal accounts, trade and distribution, and strategic partnerships.
Prior to AVEO, Jason held commercial leadership roles at 1798 Consultants and AMAG Pharmaceuticals, where he advised and led cross-functional commercialization, payer, and access strategies across multiple specialty brands and business units. Earlier in his career, he held positions of increasing responsibility at Sunovion Pharmaceuticals, Alkermes, and Bristol-Myers Squibb.
Over the course of his career, Jason has played a leadership role in the successful U.S. launch and commercialization of eight specialty products across oncology, immunology, CNS, and ultra-orphan disease areas. He is recognized for aligning strategy and execution across commercial functions to drive market adoption, patient access, and long-term organizational growth.
Jason earned a B.S. in Business Administration from Le Moyne College and an MBA from Boston College.
Agenda Sessions
Navigate the Shifting Terrain of Pharma and Biotech Commercialization
, 8:30amView Session
